Pulheim, Germany

Meike Baumgart

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Forschungszentrum Juelich Gmbh. Active years: 2021.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Meike Baumgart: Innovator in Biochemical Research

Introduction

Meike Baumgart is a prominent inventor based in Pulheim, Germany. She has made significant contributions to the field of biochemical research, particularly in the area of pyruvate carboxylase and its applications. Her work has implications for various biotechnological processes.

Latest Patents

Meike Baumgart holds a patent for "Pyruvate carboxylase and pyruvate carboxylase-encoding DNA, plasmid containing said DNA and microorganism for the production thereof, and methods for the production of products the biosynthesis of which includes oxaloacetate as precursor, and chromosome - A DNA sequence that includes at least 70% identity with respect to SEQ ID NO: 1 and further includes a triplet at position 1027-1029 that codes for alanine." This patent highlights her innovative approach to utilizing biochemical pathways for product synthesis.

Career Highlights

Throughout her career, Meike has worked with notable organizations, including Forschungszentrum Jülich GmbH. Her experience in these research institutions has allowed her to develop and refine her expertise in biochemical processes.

Collaborations

Meike has collaborated with esteemed colleagues such as Maike Kortmann and Michael Bott. These partnerships have further enriched her research and contributed to advancements in her field.

Conclusion

Meike Baumgart's contributions to biochemical research and her innovative patent demonstrate her commitment to advancing scientific knowledge. Her work continues to inspire future developments in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…